1. Home
  2. ABR vs RGNX Comparison

ABR vs RGNX Comparison

Compare ABR & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

N/A

Current Price

$4.48

Market Cap

938.4M

Sector

Real Estate

ML Signal

N/A

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

N/A

Current Price

$8.22

Market Cap

793.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ABR
RGNX
Founded
2003
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
938.4M
793.5M
IPO Year
2003
2015

Fundamental Metrics

Financial Performance
Metric
ABR
RGNX
Price
$4.48
$8.22
Analyst Decision
Hold
Strong Buy
Analyst Count
5
8
Target Price
$9.90
$28.75
AVG Volume (30 Days)
3.4M
1.2M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
15.42%
N/A
EPS Growth
N/A
18.08
EPS
N/A
N/A
Revenue
N/A
$10,393,000.00
Revenue This Year
N/A
$51.21
Revenue Next Year
N/A
$19.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
126.48
52 Week Low
$4.72
$5.46
52 Week High
$12.58
$16.19

Technical Indicators

Market Signals
Indicator
ABR
RGNX
Relative Strength Index (RSI) 31.82 33.82
Support Level N/A $5.67
Resistance Level $5.41 $11.43
Average True Range (ATR) 0.15 0.47
MACD -0.06 -0.12
Stochastic Oscillator 4.79 5.04

Price Performance

Historical Comparison
ABR
RGNX

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: